Chunlin Ou

2.8k total citations
76 papers, 1.9k citations indexed

About

Chunlin Ou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chunlin Ou has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 41 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chunlin Ou's work include Cancer-related molecular mechanisms research (32 papers), RNA modifications and cancer (21 papers) and Ferroptosis and cancer prognosis (18 papers). Chunlin Ou is often cited by papers focused on Cancer-related molecular mechanisms research (32 papers), RNA modifications and cancer (21 papers) and Ferroptosis and cancer prognosis (18 papers). Chunlin Ou collaborates with scholars based in China, United States and Saudi Arabia. Chunlin Ou's co-authors include Xiaoyun He, Gaoyan Kuang, Yongrong Wu, Hui Nie, Guiyuan Li, Jian Ma, Jianhua Zhou, Junpu Wang, Yingying Han and Zhenqiang Sun and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chunlin Ou

71 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlin Ou China 26 1.3k 897 340 266 224 76 1.9k
Jundong Zhou China 25 1.2k 0.9× 713 0.8× 386 1.1× 193 0.7× 215 1.0× 78 1.9k
Yi Bao China 22 1.2k 0.9× 787 0.9× 385 1.1× 173 0.7× 304 1.4× 44 1.7k
Hassan Yousefi United States 19 1.8k 1.3× 1.1k 1.3× 299 0.9× 368 1.4× 174 0.8× 46 2.3k
Li Yin China 27 1.4k 1.1× 877 1.0× 505 1.5× 154 0.6× 181 0.8× 99 2.0k
Pu Li China 24 1.3k 1.0× 997 1.1× 330 1.0× 173 0.7× 153 0.7× 52 1.7k
Chaoyun Pan China 19 1.0k 0.8× 668 0.7× 272 0.8× 242 0.9× 223 1.0× 29 1.5k
Yuezhen Deng China 20 1.1k 0.9× 646 0.7× 421 1.2× 330 1.2× 130 0.6× 34 1.8k
Zhaodong Han China 26 1.2k 0.9× 704 0.8× 403 1.2× 200 0.8× 414 1.8× 76 1.8k
Min Xu China 30 1.8k 1.3× 1.2k 1.3× 511 1.5× 256 1.0× 268 1.2× 101 2.5k
Delphine Garnier Canada 26 1.3k 1.0× 828 0.9× 329 1.0× 218 0.8× 137 0.6× 44 2.1k

Countries citing papers authored by Chunlin Ou

Since Specialization
Citations

This map shows the geographic impact of Chunlin Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlin Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlin Ou more than expected).

Fields of papers citing papers by Chunlin Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlin Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlin Ou. The network helps show where Chunlin Ou may publish in the future.

Co-authorship network of co-authors of Chunlin Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlin Ou. A scholar is included among the top collaborators of Chunlin Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlin Ou. Chunlin Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jing, Chunlin Ou, Xin Li, et al.. (2025). tRNA-derived small RNA 3’ tRF-Ala CGC obstructs NK cytotoxicity via cleavage of membrane protein MICA in colorectal cancer. Frontiers in Immunology. 16. 1620550–1620550.
2.
Yu, Xiaoqian, Jing Zhang, Zixin Huang, et al.. (2025). Plasma-derived exosomal tRF-3004a as a diagnostic biomarker for colorectal cancer. Scientific Reports. 15(1). 45558–45558.
3.
He, Xiaoyun, et al.. (2024). tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application. Molecular Cancer. 23(1). 27 indexed citations
4.
Nie, Hui, Chunrong Wang, Xiaoqian Yu, et al.. (2024). Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma. Journal of Cancer. 15(10). 3154–3172. 2 indexed citations
5.
Zhang, Jing & Chunlin Ou. (2024). Transfer RNA-derived small RNA serves as potential non-invasive diagnostic marker and a novel therapeutic target for acute pancreatitis. World Journal of Gastroenterology. 31(1). 99954–99954. 1 indexed citations
6.
Yu, Xiaoqian, Xuejie Yang, Hui Nie, et al.. (2023). Immunological role and prognostic value of somatostatin receptor family members in colon adenocarcinoma. Frontiers in Pharmacology. 14. 1255809–1255809. 1 indexed citations
7.
Li, Yidan, et al.. (2023). Emerging role of ferroptosis-related circular RNA in tumor metastasis. Frontiers in Pharmacology. 14. 1168458–1168458. 4 indexed citations
8.
Song, Xiangping, Qiong Huang, Yuqi Yang, et al.. (2023). Efficient Therapy of Inflammatory Bowel Disease (IBD) with Highly Specific and Durable Targeted Ta2C Modified with Chondroitin Sulfate (TACS). Advanced Materials. 35(36). e2301585–e2301585. 69 indexed citations
9.
Wu, Qihui, Xiaodan Fu, Xiaoyun He, et al.. (2023). Experimental prognostic model integrating N6-methyladenosine-related programmed cell death genes in colorectal cancer. iScience. 27(1). 108720–108720. 3 indexed citations
10.
Wu, Qihui, Xiaoyun He, Jiaxin Liu, et al.. (2023). Integrative evaluation and experimental validation of the immune-modulating potential of dysregulated extracellular matrix genes in high-grade serous ovarian cancer prognosis. Cancer Cell International. 23(1). 223–223. 2 indexed citations
11.
Li, Yimin, Ruotong Tian, Jiaxin Liu, et al.. (2022). A 13-Gene Signature Based on Estrogen Response Pathway for Predicting Survival and Immune Responses of Patients With UCEC. Frontiers in Molecular Biosciences. 9. 833910–833910. 6 indexed citations
12.
Nie, Hui, Yutong Wang, Xuejie Yang, et al.. (2021). Clinical Significance and Integrative Analysis of the SMC Family in Hepatocellular Carcinoma. Frontiers in Medicine. 8. 727965–727965. 17 indexed citations
13.
He, Xiaoyun & Chunlin Ou. (2021). Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications. World Journal of Diabetes. 12(8). 1282–1291. 1 indexed citations
14.
Wang, Yutong, Hui Nie, Zhiming Liao, et al.. (2021). Expression and Clinical Significance of Lactate Dehydrogenase A in Colon Adenocarcinoma. Frontiers in Oncology. 11. 700795–700795. 12 indexed citations
15.
He, Xiaoyun, Li Shen, Gaoyan Kuang, et al.. (2019). Up-regulation of LINC00467 promotes the tumourigenesis in colorectal cancer. Journal of Cancer. 10(25). 6405–6413. 37 indexed citations
16.
He, Xiaoyun, et al.. (2018). Circular RNA HIPK3: an emerging player in diabetes. Translational Cancer Research. 1(1). 2 indexed citations
17.
He, Xiaoyun, Gaoyan Kuang, Chunlin Ou, & Pengfei Cao. (2017). Crosstalk between circular RNAs and microRNAs in tumorigenesis. Translational Cancer Research. 6. 1 indexed citations
18.
He, Xiaoyun & Chunlin Ou. (2016). Research progress of long non-coding RNAs in diabetes. 8(3). 187–189. 1 indexed citations
19.
Sun, Zhenqiang, Weiguo Ren, Chunlin Ou, et al.. (2015). Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis. PLoS ONE. 10(8). e0135119–e0135119. 37 indexed citations
20.
Ou, Chunlin, Zhenqiang Sun, Han Zhang, et al.. (2015). SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway. Oncology Reports. 33(6). 2779–2788. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jundong Zhou Breakdown of academic impact, for papers by Yi Bao Breakdown of academic impact, for papers by Hassan Yousefi Breakdown of academic impact, for papers by Li Yin Breakdown of academic impact, for papers by Pu Li Breakdown of academic impact, for papers by Chaoyun Pan Breakdown of academic impact, for papers by Yuezhen Deng Breakdown of academic impact, for papers by Zhaodong Han Breakdown of academic impact, for papers by Min Xu Breakdown of academic impact, for papers by Delphine Garnier
Rankless by CCL
2026